Philadelphia chromosome positive acute lymphoblastic leukemia

Philadelphia chromosome-positive acute lymphoblastic leukemia is an aggressive hematologic malignancy characterized by the malignant proliferation of immature lymphoid precursor cells, primarily of B-cell lineage, within the bone marrow and peripheral blood While occurring in both pediatric and adult populations, its incidence increases markedly with age, representing roughly one-fourth of adult cases Patients typically present with systemic features of bone marrow failure, including anemia, thr...

Philadelphia chromosome-positive acute lymphoblastic leukemia is an aggressive hematologic malignancy characterized by the malignant proliferation of immature lymphoid precursor cells, primarily of B-cell lineage, within the bone marrow and peripheral blood It is pathologically defined by the t(9;22)(q34;q11.2) reciprocal chromosomal translocation that creates the Philadelphia chromosome, generating the oncogenic BCR::ABL1 fusion gene and producing a constitutively active tyrosine kinase that dr...

It is pathologically defined by the t(9;22)(q34;q11.2) reciprocal chromosomal translocation that creates the Philadelphia chromosome, generating the oncogenic BCR::ABL1 fusion gene and producing a constitutively active tyrosine kinase that drives dysregulated cell proliferation and survival

It is pathologically defined by the t(9;22)(q34;q11.2) reciprocal chromosomal translocation that creates the Philadelphia chromosome, generating the oncogenic BCR::ABL1 fusion gene and producing a constitutively active tyrosine kinase that drives dysregulated cell proliferation and survival

While occurring in both pediatric and adult populations, its incidence increases markedly with age, representing roughly one-fourth of adult cases

Patients typically present with systemic features of bone marrow failure, including anemia, thrombocytopenia, recurrent infections, fatigue, bleeding, and potential extramedullary involvement

Patients typically present with systemic features of bone marrow failure, including anemia, thrombocytopenia, recurrent infections, fatigue, bleeding, and potential extramedullary involvement